I am a Haematologist and Clinical Senior Lecturer with an interest in chimeric antigen receptor T cells (CAR T) for the treatment of haematological malignancies. I lead a Cellular Immunotherapy Group that has been focussed on developing and optimising allogeneic 'off the shelf' CAR T cells and also in deciphering the mechanisms of resistance of blood cancers to CAR T cell therapy. My clinical disease interest is multiple myeloma and we are currently investigating the pathogenesis of extramedullary myeloma as well as developing next generation flow cytometry methods for monitoring multiple myeloma.